bepridil has been researched along with Heart Diseases in 3 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bepridil has multiple ion-channel blocking effects similar to amiodarone and is expected to have anti-arrhythmic effects that are useful for the management of atrial fibrillation (AF)." | 7.73 | Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. ( Daida, H; Iida, Y; Kawano, Y; Mineda, Y; Nakata, Y; Nakazato, K; Nakazato, Y; Sasaki, A; Sumiyoshi, M; Tokano, T; Yasuda, M, 2005) |
| "Bepridil has multiple ion-channel blocking effects similar to amiodarone and is expected to have anti-arrhythmic effects that are useful for the management of atrial fibrillation (AF)." | 3.73 | Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. ( Daida, H; Iida, Y; Kawano, Y; Mineda, Y; Nakata, Y; Nakazato, K; Nakazato, Y; Sasaki, A; Sumiyoshi, M; Tokano, T; Yasuda, M, 2005) |
| "Pretreatment with bepridil for 5 min before ischemia improved the recovery of developed tension measured after 60 min of reperfusion." | 1.33 | Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection. ( Costa, AD; Garlid, KD; Ishida, H; Nakaya, H; Ogura, T; Saito, T; Sato, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakazato, Y | 1 |
| Yasuda, M | 1 |
| Sasaki, A | 1 |
| Iida, Y | 1 |
| Kawano, Y | 1 |
| Nakazato, K | 1 |
| Tokano, T | 1 |
| Mineda, Y | 1 |
| Sumiyoshi, M | 1 |
| Nakata, Y | 1 |
| Daida, H | 1 |
| Sato, T | 1 |
| Costa, AD | 1 |
| Saito, T | 1 |
| Ogura, T | 1 |
| Ishida, H | 1 |
| Garlid, KD | 1 |
| Nakaya, H | 1 |
| Flammang, D | 1 |
| Waynberger, M | 1 |
| Jansen, FH | 1 |
| Paillet, R | 1 |
| Coumel, P | 1 |
3 other studies available for bepridil and Heart Diseases
| Article | Year |
|---|---|
Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Electrocardio | 2005 |
Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
Topics: Algorithms; Animals; Anti-Arrhythmia Agents; Bepridil; Cell Line; Cell Separation; Coronary Circulat | 2006 |
Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Bepridil; Calcium Channel Blockers; Electrocardi | 1983 |